Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature

Immediate reduction of white blood cell count after tocilizumab administration was observed in some cases

(2014) Ryuji Nagamine et al.   Modern Rheumatology

Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions

(2014) Norihiro Nishimoto et al.   Modern Rheumatology

Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo

(2014) Helen L. Wright et al.   RHEUMATOLOGY

A45: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis

(2014) Fabrizio De Benedetti et al.   Arthritis & Rheumatology

A14: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis

(2014) Fabrizio De Benedetti et al.   Arthritis & Rheumatology

Successful Use of Tocilizumab in a Patient With Rheumatoid Arthritis Following Severe Pancytopenia During Etanercept Therapy

(2012) Balázs Szalay et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Re-challenge with Etanercept in patients with Etanercept-induced Neutropenia

(2011) Muhammad Haroon et al.   CLINICAL RHEUMATOLOGY

Neutropenia in patients receiving anti-tumor necrosis factor therapy

(2010) Richard Hastings et al.   ARTHRITIS CARE & RESEARCH

Tocilizumab

(2009) Vicki Oldfield et al.   DRUGS

Adalimumab-induced neutropenia in a patient with rheumatoid arthritis

(2009) Sébastien Ottaviani et al.   JOINT BONE SPINE

Blockade of Interleukin 6 Signaling Induces Marked Neutropenia in Patients with Rheumatoid Arthritis

(2009) I. NAKAMURA et al.   JOURNAL OF RHEUMATOLOGY

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM